Explanipedia

COVID-19 and chronic liver disease: results from the 1219 patients French registry Open

Lorraine Blaise, Fanny Lebossé, Charlotte Costentin, Shahid Ahmed, Alexandra Heurgué , et al. · 2025

Corrigendum to: “Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study” [J Hepatol (2024) 278-288] Open

Catherine Lamarque, Lauriane Ségaux, Philippe Bachellier, Benjamin Buchard, Faïza Chermak , et al. · 2025

Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions Open

Valentine Marie Ferré, Axelle Dupont, Mélanie Draullette, Emy Valette, Gilles Collin , et al. · 2025

Alcohol Consumption After Listing for Liver Transplantation Is Associated With Increased Risk of Alcohol Consumption After Transplantation Open

Léa Abrial, Domitille Erard, Laure Tron, Sylvie Radenne, Agnès Bonadona , et al. · 2025

Background: Alcohol abstinence is required before liver transplantation (LT) for alcohol‐related liver disease (ALD). However, some patients may have alcohol intake during the pretransplant period. Objectives: Describe the prevalence of al…

COVID-19 and chronic liver disease: results from the 1219 patients French registry Open

Lorraine Blaise, Jérôme Dumortier, Nathalie Ganne‐Carrié, Fanny Lebossé, Charlotte Costentin , et al. · 2024

The negative impact of Coronavirus SARS CoV-2 related Disease (COVID-19) in patients with chronic liver disease (CLD) has been described in several cohorts. We report here the results from the largest French cohort in “real-life”. The prim…

Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study Open

Catherine Lamarque, Lauriane Ségaux, Philippe Bachellier, Benjamin Buchard, Faïza Chermak , et al. · 2024

To maximize utility and prevent premature liver transplantation (LT), a delayed LT strategy was adopted in France in 2015. It involves postponing LT until recurrence in patients listed for any single HCC curatively treated by surgical rese…

Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development Open

Yasmina Chouik, Mathilde Di Filippo, Sylvie Radenne, Jérôme Dumortier, Philippe Moulin , et al. · 2024

International audience

Herpes Simplex Virus Hepatitis in Patients Requiring Intensive Care Unit Admission: A Retrospective, Multicenter, Observational Study Open

Thomas Frapard, Giuliana Amaddeo, Maxens Decavèle, Paër-Sélim Abback, Antoine Gaillet , et al. · 2023

The clinical features and short-term prognosis of patients admitted to the intensive care unit for herpes hepatitis are lacking. Of 33 patients admitted between 2006 and 2022, 22 were immunocompromised, 4 were pregnant women, and 23 died. …

Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis Open

Yasmina Chouik, Fanny Lebossé, Marie‐Laure Plissonnier, Jean‐Christophe Lega, Pierre Pradat , et al. · 2023

Bacterial infections are the most frequent precipitating event in patients with acute decompensation of cirrhosis (AD) and are associated with high mortality. Early diagnosis is challenging due to cirrhosis-related systemic inflammation. H…

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis Open

François Villeret, Fanny Lebossé, Sylvie Radenne, Didier Samuel, Bruno Roche , et al. · 2023

Long‐term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years Open

Yasmina Chouik, Olivier Chazouillères, Claire Francoz, Eleonora De Martin, Olivier Guillaud , et al. · 2023

Background & Aims Autoimmune hepatitis (AIH) is a rare indication for liver transplantation (LT). The aims of this study were to evaluate long‐term survival after LT for AIH and prognostic factors, especially the impact of recurrent AIH (r…

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years? Open

Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, Sylvie Radenne, Anaïs Vallet‐Pichard , et al. · 2022

Background: Direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection have been proven safe and effective in cirrhotic patients awaiting liver transplantation (LT). However, in the long term, data remain m…

Liver transplantation for autoimmune hepatitis: Pre‐transplant does not predict the early post‐transplant outcome Open

Yasmina Chouik, Claire Francoz, Eléonora De Martin, Olivier Guillaud, Armand Abergel , et al. · 2022

Background and Aims Autoimmune hepatitis (AIH) is a rare indication (<5%) for liver transplantation (LT). The aim of this study was to describe the early outcome after LT for AIH. Methods A multicenter retrospective nationwide study includ…

AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool Open

Federico Piñero, Charlotte Costentin, Helena Degroote, Andrea Notarpaolo, Ilka de Fátima Santana Ferreira Boin , et al. · 2022

Location and allocation Open

Thierry Artzner, William Bernal, L Belli, Sara Conti, Paolo Angelo Cortesi , et al. · 2022

There is growing evidence that liver transplantation (LT) is the most effective treatment for acute-on-chronic liver failure grade-3 (ACLF-3). This study examines whether and how this evidence translates into practice by analyzing the vari…

R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation Open

Charlotte Costentin, Federico Piñero, Helena Degroote, Andrea Notarpaolo, Ilka de Fátima Santana Ferreira Boin , et al. · 2022

COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study Open

L Belli, Christophe Duvoux, Paolo Angelo Cortesi, Rita Facchetti, Speranţa Iacob , et al. · 2021

Objective Explore the impact of COVID-19 on patients on the waiting list for liver transplantation (LT) and on their post-LT course. Design Data from consecutive adult LT candidates with COVID-19 were collected across Europe in a dedicated…

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria Open

Helena Degroote, Federico Piñero, Charlotte Costentin, Andrea Notarpaolo, Ilka de Fátima Santana Ferreira Boin , et al. · 2021

Microsporidiosis after liver transplantation: A French nationwide retrospective study Open

Jérôme Dumortier, Sylvie Radenne, Nassim Kamar, Filoména Conti, Armand Abergel , et al. · 2021

Background Microsporidiosis has been largely reported in patients with acquired immunodeficiency syndrome, but emerged as a cause of persistent diarrhea in solid organ transplant patients. Methods Through the French Microsporidiosis Networ…

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model Open

Bleuenn Brusset, Jérôme Dumortier, Daniel Cherqui, Georges‐Philippe Pageaux, Emmanuel Boleslawski , et al. · 2021

Purpose: To compare the agreement for the criteria on the explant and the results of liver transplantation (LT) before and after adoption of the AFP (α-fetoprotein) model. Methods: 523 patients consecutively listed in five French centers w…

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS) Open

L Belli, Christophe Duvoux, Thierry Artzner, William Bernal, Sara Conti , et al. · 2021

Liver Transplantation for Colorectal Liver Metastases: Current Management and Future Perspectives Open

Serban Puia‐Negulescu, Fanny Lebossé, Jean-Yves Mabrut, Xavier Muller, Guillaume Rossignol , et al. · 2021

Patients with nonresectable liver metastases from colorectal cancer have few therapeutic options and a dismal prognosis. Although liver transplantation for this indication has historically a poor reputation, recent advances in the field of…

Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients Open

Mario Altieri, Olivier Serée, Thierry Lobbedez, P Ségol, Armand Abergel , et al. · 2021

Covid-19 in liver transplant recipients: the French SOT COVID registry Open

Jérôme Dumortier, Christophe Duvoux, Olivier Roux, Mario Altieri, Hélène Barraud , et al. · 2021

Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score Open

Eléonora De Martin, Audrey Coilly, Olivier Chazouillères, Olivier Roux, Jean‐Marie Péron , et al. · 2021

COVID-19 in Liver Transplant Candidates: Pre- and Post-Transplant Outcome Open

L Belli, Christophe Duvoux, Paolo Angelo Cortesi, Speranţa Iacob, Rita Facchetti , et al. · 2021

Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study Open

L Belli, Constantino Fondevila, Paolo Angelo Cortesi, Sara Conti, Vincent Karam , et al. · 2020

Long term results of liver transplantation for alpha-1 antitrypsin deficiency Open

Olivier Guillaud, Emmanuel Jacquemin, Eduardo Couchonnal, Claire Vanlemmens, Claire Francoz , et al. · 2020

Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study Open

L Belli, Christophe Duvoux, Giovanni Perricone, Georges‐Philippe Pageaux, Magdalena Meszaros , et al. · 2020

Prospective study of HBV cccDNA kinetics in a French multicenter cohort of liver transplant patients (ECOGREFFE) reveals very early graft infection despite NUC+HBIG prophylaxis Open

François Villeret, Fanny Lebossé, Sylvie Radenne, Didier Samuel, Bruno Roche , et al. · 2020

Sylvie Radenne YOU? Author Swipe